ASLAN PHARMACEUTICALS : REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Form 6-K -April 12, 2024 at 06:07 am EDT

ASLAN PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE


-

In a preliminary review of blinded data from the...

Related Keywords

California ,United States ,Singapore ,Ashleyr Robinson ,Ramaswamy Krishnan ,Carl Firth ,Aprilw Armstrong ,Reynold Panettieri Jr ,Jonathan Silverberg ,Emma Thompson ,Rutgers University ,Health Sciences ,Linkedin ,Lifesci Advisors ,Company Us Securities ,Spurwing Communications ,Company Annual Report On Form ,George Washington University School Of Medicine ,European Patent Office ,Harvard Medical School ,International Examiner ,Exchange Commission On ,Pharmaceuticals Nasdaq ,Exchange Commission ,Dermatology Drug Development Summit ,Clinical Research Organization ,Commission File No ,Company American Depositary Shares Adss ,European Congress ,Stockholders Of The Company ,Annual European Congress ,George Washington University School ,Investigator Global Assessment ,Associate Professor ,Emergency Medicine ,Vice Chancellor ,Translational Medicine ,American Depositary Shares ,Three Months ,Twelve Months ,San Mateo ,Commission File ,Annual Report ,Sci Advisors ,